Endovascular Thrombectomy for Acute Ischemic Stroke in Failed Intravenous Tissue Plasminogen Activator Versus Non-Intravenous Tissue Plasminogen Activator Patients Revascularization and Outcomes Stratified by the Site of Arterial Occlusions

被引:69
作者
Shi, Zhong-Song [3 ]
Loh, Yince [4 ]
Walker, Gary [2 ]
Duckwiler, Gary R. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Intervent Neuroradiol, Los Angeles, CA 90095 USA
[2] Concentr Med Inc, Mountain View, CA USA
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510275, Guangdong, Peoples R China
[4] Madigan Army Med Ctr, Dept Med, Neurovasc Serv, Tacoma, WA 98431 USA
关键词
acute stroke; endovascular treatment; outcome; thrombectomy; thrombolysis; MECHANICAL EMBOLUS REMOVAL; THROMBOLYTIC THERAPY; INTRAARTERIAL THROMBOLYSIS; CLOT DISRUPTION; MERCI; RECANALIZATION; ALTEPLASE; ATLANTIS; SAFETY; ECASS;
D O I
10.1161/STROKEAHA.109.568451
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Intracranial mechanical thrombectomy is a therapeutic option for acute ischemic stroke patients failing intravenous tissue plasminogen activator (IV tPA). We compared patients treated by mechanical embolus removal in cerebral ischemia (MERCI) thrombectomy after failed IV tPA with those treated with thrombectomy alone. Methods-We pooled MERCI and Multi MERCI study patients, grouped them either as failed IV tPA or non-IV tPA, and assessed revascularization rates, procedural complications, symptomatic hemorrhage rates, clinical outcomes, and mortality. We also evaluated outcomes stratified by the occlusion site and final revascularization. Results-Among 305 patients, 48 failed, and 257 were ineligible for IV tPA. Nonresponders to IV tPA trended toward a higher revascularization rate (73% versus 63%) and less mortality (27.7% versus 40.1%) and had similar rates of symptomatic hemorrhage and procedural complications. Favorable 90-day outcomes were similar in failed and non-IV tPA patients (38% versus 31%), with no difference according to occlusion site. Among patients failing IV tPA, good outcomes tended to occur more frequently in revascularized patients (47.1% versus 15.4%), although this relationship was attributable solely to middle cerebral artery and not internal carotid artery occlusions, with no difference in mortality. Among IV tPA-ineligible patients, revascularization correlated with good outcome (47.4% versus 4.4%) and less mortality (28.5% versus 59.6%). Conclusions-The risks of hemorrhage and procedure-related complications after mechanical thrombectomy do not differ with respect to previous IV tPA administration. Thrombectomy after IV tPA achieves similar rates of good outcomes, a tendency toward lower mortality, and similar revascularization rates when stratified by clot location. Good outcomes correlate with successful revascularization except with internal carotid artery occlusions in tPA-nonresponders. (Stroke. 2010; 41: 1185-1192.)
引用
收藏
页码:1185 / 1192
页数:8
相关论文
共 28 条
[1]   The interventional management of stroke (IMS) II study [J].
Broderick, Joseph P. .
STROKE, 2007, 38 (07) :2127-2135
[2]   Endovascular Interventions following Intravenous Thrombolysis May Improve Survival and Recovery in Patients with Acute Ischemic Stroke: A Case-Control Study [J].
Burns, T. C. ;
Rodriguez, G. J. ;
Patel, S. ;
Hussein, H. M. ;
Georgiadis, A. L. ;
Lakshminarayan, K. ;
Qureshi, A. I. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (10) :1918-1924
[3]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[4]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[5]   Mechanical thrombectomy of intracranial internal carotid occlusion - Pooled results of the MERCI and multi MERCI part I trials [J].
Flint, Alexander C. ;
Duckwiler, Gary R. ;
Budzik, Ronald F. ;
Liebeskind, David S. ;
Smith, Wade S. .
STROKE, 2007, 38 (04) :1274-1280
[6]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[7]   MERCI 1 - A phase 1 study of mechanical embolus removal in cerebral ischemia [J].
Gobin, YP ;
Starkman, S ;
Duckwiler, GR ;
Grobelny, T ;
Kidwell, CS ;
Jahan, R ;
Pile-Spellman, J ;
Segal, A ;
Vinuela, F ;
Saver, JL .
STROKE, 2004, 35 (12) :2848-2853
[8]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[9]   Hemorrhage in the interventional management of stroke study [J].
Wechsler L.R. .
STROKE, 2006, 37 (03) :847-851
[10]  
Lee KY, 2004, AM J NEURORADIOL, V25, P1470